H. Dhingra

发表

Ifosfamide with Mesna Uroprotection in the Management of Lung Cancer

W. Hong, J. S. Lee, M. Raber, 1990, American journal of clinical oncology.

Cutaneous and subcutaneous metastases of lung cancer. Clinical characteristics.

M. Valdivieso, S. Dreizen, H. Dhingra, 1986, Postgraduate medicine.

The role of adjuvant surgery in the combined modality therapy of small-cell bronchogenic carcinoma after a chemotherapy-induced partial remission.

C. Mountain, M. Valdivieso, D. Carr, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I trial of oral talactoferrin alfa in refractory solid tumors

G. Varadhachary, T. Hayes, A. Varadhachary, 2006, Investigational New Drugs.

Esophageal complications from combined chemoradiotherapy (cyclophosphamide + Adriamycin + cisplatin + XRT) in the treatment of non-small cell lung cancer.

D. Booser, M. Valdivieso, H. Barkley, 1985, International journal of radiation oncology, biology, physics.

High‐dose chemotherapy and autologous bone marrow transplantation for the treatment of small cell lung carcinoma

M. Valdivieso, G. Spitzer, K. A. Dicke, 1983, Cancer.

Antineoplastic Chemotherapy of Advanced Lung Cancer

D. Booser, G. Bodey, M. Valdivieso, 1982 .

High-dose intensification therapy with autologous bone marrow support for limited small-cell bronchogenic carcinoma.

A. Zander, M. Valdivieso, W. Murphy, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II Pilot Study with Cisplatin, Etoposide, and Continuous‐Infusion 5‐Fluorouracil in Metastatic Non‐small Cell Lung Cancer

W. Murphy, J. Lee, P. Holoye, 1987, American journal of clinical oncology.

Primary chemotherapy of brain metastasis in small-cell lung cancer.

W. Murphy, B. Glisson, J. Lee, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Use of carcinoembryonic antigen in small cell lung cancer prognostic value and relation to the clinical course 1

H. Fritsche, M. Valdivieso, D. Carr, 1987, Cancer.

Phase II study of tiazofurin (NSC 286193) in the treatment of advanced small cell bronchogenic carcinoma

D. Carr, W. Murphy, B. Glisson, 1988, Investigational New Drugs.

Primary therapy for small cell lung cancer reversing the Eaton-Lambert syndrome.

H. Dhingra, P. Farha, S. Kalter, 1985, Southern medical journal.

A phase I trial of recombinant alpha-2a Interferon (Roferon-A) with weekly cisplatinum

J. Ajani, J. Gutterman, K. Dhingra, 1991, Investigational New Drugs.

Phase II study of taxol in patients with untreated advanced non-small-cell lung cancer.

R. Winn, F. Fossella, D. Shin, 1993, Journal of the National Cancer Institute.

Randomized trial of three combinations of cisplatin with vindesine and/or VP-16-213 in the treatment of advanced non-small-cell lung cancer.

M. Valdivieso, D. Carr, W. Murphy, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study of spirogermanium in advanced (extensive) non-small cell lung cancer.

M. Valdivieso, W. Murphy, G. Spitzer, 1986, Cancer treatment reports.

Phase II study of 5,6-dihydro-5-azacytidine in extensive, untreated non-small cell lung cancer.

D. Carr, W. Murphy, J. Lee, 1987, Cancer treatment reports.

Phase II trial of 5,6-dihydro-5-azacytidine in pleural malignant mesothelioma

W. Hong, R. Winn, M. Raber, 1991, Investigational New Drugs.

A case report of malignant pleural mesothelioma with long‐term disease control after chemotherapy

C. Charnsangavej, M. Luna, H. Dhingra, 1991, Cancer.

Weekly doxorubicin versus doxorubicin every 3 weeks in cyclophosphamide, doxorubicin, and cisplatin chemotherapy for non‐small cell lung cancer

D. Booser, M. Valdivieso, D. Carr, 1989, Cancer.

Combined chemoradiotherapy in limited-disease, inoperable non-small cell lung cancer.

D. Booser, M. Valdivieso, D. Carr, 1988, International journal of radiation oncology, biology, physics.

Timing of elective brain irradiation: a critical factor for brain metastasis-free survival in small cell lung cancer.

M. Valdivieso, H. Barkley, W. Murphy, 1987, International journal of radiation oncology, biology, physics.

Intrapleural etoposide for malignant effusion

F. Holmes, R. Newman, M. Raber, 2008, Cancer Chemotherapy and Pharmacology.

Effects of brain irradiation and chemotherapy on myelosuppression in small-cell lung cancer.

H. Barkley, W. Murphy, J. Lee, 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Combination chemotherapy with vindesine and cisplatin for refractory small cell bronchogenic carcinoma.

G. Bodey, M. Valdivieso, D. Carr, 1986, Cancer treatment reports.

I.v. melphalan in carcinoma of the lung: effect of cyclophosphamide priming on hematopoietic toxicity.

M. Valdivieso, W. Murphy, G. Spitzer, 1986, Cancer treatment reports.